The content of matrix metalloproteinase-1,-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity

被引:0
|
作者
Kachkovska, V. V. [1 ]
Prystupa, L. N. [2 ]
机构
[1] Sumy State Univ, Ctr Resp Med, Dept Internal Med, UA-40007 Sumy, Ukraine
[2] Sumy State Univ, Ctr Resp Med, Internal Med, Sumy, Ukraine
来源
PATHOLOGIA | 2023年 / 20卷 / 03期
关键词
asthma; obesity; matrix metalloproteinase-1; matrix metalloproteinase-9; tissue inhibitor of metalloproteinase-1; course; control;
D O I
10.14739/2310-1237.2023.3.291212
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Airway remodeling is a significant factor in the progression of respiratory failure in bronchial asthma (BA). Obesity can contribute to inflammation, and consequently - airway remodeling, by increased production of matrix proteinase (MMP). However, the mechanisms of remodeling in different phenotypes of BA, especially in comorbid patients, remain poorly understood.The aim of the research was to examine the levels of remodeling markers MMP-1, MMP-9 and tissue inhibitor of matrix proteinases (TIMP-1) in obese asthmatic patients, taking into account their age at the onset of BA, the severity of symptoms and the level of control. Material and methods. 195 patients with BA associated with obesity were examined. The control group consisted of 95 practically healthy people. Patients were divided into two groups: Group I included 100 patients with early onset, and Group II included 95 patients with late onset of BA. The study was approved by the Bioethics Commission of the Medical Institute of Sumy State University. Statistical analysis of the obtained results was carried out using the SPSS-17 program.Results. The content of MMP-1,-9 and TIMP-1 was higher in patients with early (129.40 +/- 7.86; 177.30 +/- 9.19; 142.40 +/- 12.22 ng/ml, respectively) and late (196.60 +/- 9.62; 289.80 +/- 16.23; 187.50 +/- 11.34 ng/ml, respectively) BA with obesity compared to practically healthy individuals (p < 0.005). Patients with late-onset BA associated with obesity likely had higher indicators than those with early BA. In patients with early BA, the levels of MMP-1,-9, and TIMP-1 were not significantly different depending on the severity of the disease (p > 0.05). However, in patients with severe late BA, the levels of these markers were higher compared to those with mild BA (p < 0.05). Levels of MMP-1 and MMP-9 in patients with early-onset and late-onset BA with obesity were higher in the absence of disease control compared to those in complete and partial control, but in late-onset exceeded those in early-onset.Conclusions. Considering the obtained results, it can be assumed that the level of MMP-1, MMP-9 and TIMP-1 in obese patients with BA can serve as biomarkers of airway remodeling, namely, the severity and the level of BA control.
引用
收藏
页码:238 / 242
页数:5
相关论文
共 50 条
  • [21] Tissue inhibitor of matrix metalloproteinase-1: mediator of neuroinflammation?
    Althoff, Gioia
    Humar, Dea
    Pagenstecher, Axel
    [J]. NEURON GLIA BIOLOGY, 2007, 2 : S97 - S97
  • [22] Levels of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 in gastric cancer
    Kemik, Ozgur
    Kemik, Ahu Sarbay
    Sumer, Aziz
    Dulger, Ahmet Cumhur
    Adas, Mine
    Begenik, Huseyin
    Hasirci, Ismail
    Yilmaz, Ozkan
    Purisa, Sevim
    Kisli, Erol
    Tuzun, Sefa
    Kotan, Cetin
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (16) : 2109 - 2112
  • [23] Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio
    Doherty, GM
    Kamath, SV
    de Courcey, F
    Christie, SN
    Chisakuta, A
    Lyons, JD
    Heaney, LG
    Ennis, M
    Shields, MD
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (09): : 1168 - 1174
  • [24] Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma
    Mautino, G
    Henriquet, C
    Gougat, C
    Le Cam, A
    Dayer, JM
    Bousquet, J
    Capony, F
    [J]. LABORATORY INVESTIGATION, 1999, 79 (01) : 39 - 47
  • [25] Interplay between matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in acute asthma exacerbation and airway remodeling
    Mohamed, Ghada Mahmoud
    Farres, Mohamed Nazmy
    Mahmoud, Hala
    [J]. EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2012, 61 (03): : 35 - 39
  • [26] Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients
    Duda, Izabela
    Krzych, Lukasz
    Jedrzejowska-Szypulka, Halina
    Lewin-Kowalik, Joana
    [J]. OPEN MEDICINE, 2020, 15 (01): : 50 - 56
  • [27] CELL DISTRIBUTION DIFFERENCES OF MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE-1 IN PATIENTS WITH KAWASAKI DISEASE
    Korematsu, Seigo
    Ohta, Yoko
    Tamai, Naotaka
    Takeguchi, Masahiro
    Goto, Chika
    Miyahara, Hiroaki
    Kawano, Tatsuya
    Izumi, Tatsuro
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (09) : 973 - 974
  • [28] Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans
    Dellalibera-Joviliano, Renata
    Jacob-Ferreira, Anna L. B.
    Joviliano, Edwaldo Edner
    Tanus-Santos, Jose E.
    Evora, Paulo R. B.
    [J]. VASCULAR MEDICINE, 2012, 17 (02) : 73 - 78
  • [29] Evaluation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 levels in gingival fibroblasts of cyclosporin A-treated patients
    Tüter, G
    Serdar, MA
    Yalim, M
    Gürhan, IS
    Balos, K
    [J]. JOURNAL OF PERIODONTOLOGY, 2002, 73 (11) : 1273 - 1278
  • [30] Glomerular Protein Levels of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 Are Lower in Diabetic Subjects
    Cornish, Toby C.
    Bagnasco, Serena M.
    Macgregor, Anne M.
    Lu, Jie
    Selvin, Elizabeth
    Halushka, Marc K.
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2009, 57 (11) : 995 - 1001